Helene Vitali | Infant Vision Perception | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Helene Vitali | Infant Vision Perception | Best Researcher Award

Istituto Italiano di Tecnologia | Italy

Dr. Helene Vitali is an accomplished Italian researcher and postdoctoral scholar at the Italian Institute of Technology, where she leads the MELD Consortium at the Unit for Visually Impaired People, investigating the role of movement on multisensory perception in children and its impact on behavioral performance in ADHD. She holds a Ph.D. in Bioengineering and Robotics with a focus on cognitive robotics, interaction, and rehabilitation technologies, a master’s in Neurobiology, and a bachelor’s in Neurophysiological Techniques, demonstrating a strong academic foundation in neuroscience, neurophysiology, and developmental cognitive science. Her professional experience includes extensive research fellowships, visiting researcher appointments, and clinical collaborations in EEG and fMRI studies, exploring neural activity in blind and sighted individuals, sleep microstructures, and multisensory integration. Her research interests encompass multisensory perception, neurodevelopment, sleep, sensorimotor processing, and neuroplasticity, with applications in developmental disorders and sensory impairment. She is proficient in electrophysiological and neuroimaging techniques, data analysis, experimental design, and cognitive assessment, with a robust publication record in high-impact journals and conference proceedings. Recognized with multiple awards, including the Trainee Professional Development Award from the Society of Neuroscience and the Young Technician Communication Challenge, she is an active member of leading scientific societies, contributes to science communication, and mentors students and Ph.D. candidates. In conclusion, Helene Vitali exemplifies a dedicated scholar whose integrated expertise in neurodevelopment, multisensory processing, and applied research advances both fundamental neuroscience and practical interventions for visually impaired and neurodiverse populations.

Profile: Google scholar

Featured Publications

Chengfang Tang | Newborn Screening | Best Researcher Award

Published on by Cognitive Scientist Awards

Mrs. Chengfang Tang | Newborn Screening | Best Researcher Award

Guangzhou Medical University | China

Chengfang Tang, a supervising technician at Guangzhou Newborn Screening Center, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, holds a Master’s degree from Sun Yat-sen University with specialization in instrumental analysis in Pharmaceutical Analysis. With extensive professional experience, she has dedicated her career to clinical and research work on tandem mass spectrometry for newborn screening of multiple genetic metabolic diseases, contributing significantly to early detection and management of rare disorders. She also serves as Secretary of the Genetic Metabolism Group of the Rare Disease Branch of the Guangdong Medical Association, reflecting her leadership in the field. Her research interests center on newborn screening, with notable contributions in advancing diagnostic techniques for genetic metabolic conditions. She has published impactful research in high-quality journals, including International Journal of Neonatal Screening and Clinica Chimica Acta, and has conducted studies on newborn screening for adrenoleukodystrophy. Skilled in advanced laboratory techniques, mass spectrometry applications, and clinical data interpretation, her expertise supports precision medicine and improved child health outcomes. Recognized for her commitment, she has earned professional honors through memberships and leadership roles in scientific associations. Overall, Chengfang Tang’s work exemplifies excellence in research and innovation, strengthening global newborn screening efforts and improving pediatric healthcare.

Profile: ORCID

Featured Publications

Khalid Alansari | Child Abuse | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Khalid Alansari | Child Abuse | Best Researcher Award

Sidra Medical and Research Center |Qatar

Dr. Khalid Alansari is a highly accomplished pediatric emergency medicine physician with an extensive academic and clinical background. He is board-certified in Pediatrics and Pediatric Emergency Medicine by the American Board and the Royal College of Physicians and Surgeons of Canada. He currently serves as a senior leader in Pediatric Emergency Services in Qatar, holding several key positions including Chair of the Teaching Committee and Director of Pediatric Emergency Courses at Hamad Medical Corporation. Dr. Alansari is also a former Assistant Professor of Clinical Pediatrics at Weill Cornell Medical College – Qatar. He has played a vital role in developing medical education, fellowship programs, and emergency preparedness courses in collaboration with international organizations such as WHO and AAP. With decades of dedicated service, he has made significant contributions to medical training, curriculum development, and emergency care in pediatric populations across the Middle East.

Profile

ORCID

Education

Dr. Khalid Alansari’s educational journey reflects his commitment to excellence in pediatric medicine. He is board-certified by the American Board of Pediatrics and the Sub-board of Pediatric Emergency Medicine. He is also certified by the Royal College of Physicians and Surgeons of Canada in both Pediatrics  and Pediatric Emergency Medicine. His pursuit of continuous medical education includes certifications in Advanced Pediatric Life Support, Pediatric Life Support, and research ethics courses from CITI Program, preparing him for clinical, research, and administrative excellence. These academic achievements have enabled him to lead initiatives that shape pediatric emergency education and systems. His education has laid a strong foundation for a prolific career in teaching, clinical excellence, and healthcare leadership both nationally and internationally.

Experience

Dr. Alansari has held numerous prestigious clinical and academic roles across Canada and Qatar. He served as Chief Fellow in Pediatric Emergency Medicine at the Hospital for Sick Children, Toronto, in 2005. In Qatar, he has led pediatric emergency services for nearly two decades. He is the Chair of the Teaching Committee for Pediatric Emergency Centers and the Director of multiple pediatric emergency training programs, including triage and disaster response. He played a foundational role in shaping the Pediatric Emergency Fellowship Program and has served as an examiner for the Arab Board of Emergency Medicine across multiple years. As Assistant Professor at Weill Cornell Medical College – Qatar, he mentored future physicians while developing academic curricula. His clinical leadership extends to involvement in respiratory therapy education and pediatric resuscitation training. His multidimensional experience highlights a commitment to improving emergency care systems and building medical capacity regionally.

Awards and Honors

Dr. Khalid Alansari has received widespread recognition for his leadership and service in pediatric emergency medicine. His certifications and recertifications from the American Board of Pediatrics and the Royal College of Physicians and Surgeons of Canada highlight his standing in North American medicine. He was appointed Director of the Pediatric in Disaster Course, a program accredited by the World Health Organization, Pan American Health Organization, and American Academy of Pediatrics, reflecting international recognition of his expertise. His recurring roles as examiner for the Arab Board of Emergency Medicine further illustrate his trusted authority in the field. His long-standing leadership positions at Hamad Medical Corporation also point to institutional confidence in his capabilities. While specific awards were not listed, the caliber and continuity of appointments he has received are clear indicators of professional distinction and honor in global pediatric emergency circles.

Research Focus

While specific research publications are not detailed here, Dr. Khalid Alansari’s focus appears to be on clinical education, pediatric emergency care systems, triage protocols, disaster preparedness, and medical simulation training. His leadership in developing fellowship and disaster response training courses—accredited by leading global health organizations—underscores a strong emphasis on translational and applied research in pediatric emergency readiness. As an instructor of Advanced Pediatric Life Support and Pediatric Life Support courses, his work bridges the gap between academic theory and clinical application. His active role in curriculum development, evaluation, and capacity building through continuous education reflects a practice-based research approach, targeting outcomes in pediatric patient safety, acute care delivery models, and response frameworks for mass casualty scenarios. These areas are increasingly critical as healthcare systems worldwide strengthen resilience to pediatric emergencies, pandemics, and disasters. Dr. Alansari’s work informs both regional standards and global emergency medicine education

Publications

Title: How Artificial Intelligence Revolutionizing Digital Marketing
Year: 2023
Citation Count: 3

Title: Vaccine evaluation and genotype characterization in children infected with rotavirus in Qatar
Year: 2023
Citation Count: 5

Title: Clinical Presentation and Outcome of Multiple Rare Earth Magnet Ingestions in Children of Qatar. A Single-Center Experience
Year: 2023
Citation Count: 1

Conclusion

Dr. Khalid Alansari exemplifies excellence in pediatric emergency medicine through his international board certifications, leadership in medical education, development of accredited pediatric disaster preparedness programs, and unwavering commitment to clinical excellence, training, and service in Qatar and beyond.

 

Jaqueline Scholz | Prevention – Public Politic | Best Research Article Award

Published on by Cognitive Scientist Awards

Dr. Jaqueline Scholz | Prevention – Public Politic | Best Research Article Award

Dr. Jaqueline Ribeiro Scholz, MD, PhD, is a distinguished cardiologist and academic based at the Instituto do Coração (InCor), Universidade de São Paulo, Brazil. Renowned for her pioneering work in tobacco control, Dr. Scholz has made significant contributions to cardiovascular health through clinical innovation, research, and public policy. She directs the Smoking Cessation Program at InCor, offering advanced treatment modalities for tobacco dependency and developing innovative digital tools such as the PAF software and COVID-19 cessation chatbot. Her expertise has been instrumental at state, national, and global levels, including collaborations with the World Health Organization’s Tobacco or Health Program. Dr. Scholz’s commitment extends beyond clinical practice into impactful public health advocacy, contributing to legislation and preventive programs aimed at reducing tobacco-related harm globally. Her work aligns closely with international efforts to combat non-communicable diseases, positioning her as a global leader in preventive cardiology and tobacco cessation.

Profile

🎓 Education

Dr. Jaqueline Scholz received her medical training and specialized education entirely at the prestigious Universidade de São Paulo, Brazil. She completed her Residency in Cardiology at the Instituto do Coração (InCor), gaining extensive clinical expertise in cardiovascular medicine. Pursuing her academic ambitions, she specialized further with a degree in Cardiopneumology at Faculdade de Medicina da USP, equipping her with a comprehensive understanding of cardiopulmonary diseases and their systemic impacts. In 2002, Dr. Scholz earned her PhD in Cardiology from Universidade de São Paulo, focusing her research on the intersection of tobacco use and cardiovascular health. Her academic foundation has underpinned her multidisciplinary approach to clinical care, research, and public health advocacy, blending cutting-edge science with practical interventions aimed at tobacco cessation. This strong educational background has positioned her as a respected authority in preventive cardiology, with a special emphasis on combating the global tobacco epidemic.

🧪 Experience

Dr. Jaqueline Scholz has over three decades of progressive experience in clinical cardiology, research, and public health policy. Since 2003, she has served as Director of the Smoking Cessation Program at Instituto do Coração (InCor), São Paulo, leading innovative cessation strategies, including the development of patient-support technologies like the PAF software and a COVID-19 chatbot for smokers. Between 1995 and 1996, she contributed her expertise to the São Paulo State Health Department’s Commission on Tobacco Control, directly influencing state-level anti-tobacco policies and campaigns. Earlier, from 1993 to 1996, Dr. Scholz served as a medical collaborator with the World Health Organization’s Tobacco or Health Program, participating in global strategy development for tobacco reduction. Her multifaceted career bridges clinical innovation, technology integration, public health leadership, and international policy advising, marking her as a key figure in tobacco control and preventive cardiovascular care on both national and global stages.

🏅 Awards and Honors

Although specific awards are not listed, Dr. Jaqueline Scholz’s career is marked by distinguished recognition through her leadership roles and global collaborations. Being appointed as Director of the Smoking Cessation Program at one of Brazil’s most prestigious cardiology institutes reflects professional excellence. Her selection to serve on the São Paulo State Commission on Tobacco Control and as a collaborator with the World Health Organization underscores her expertise and international reputation in tobacco control. Her innovative development of patient-centric tools such as the PAF software and the COVID-19 cessation chatbot has further garnered professional acclaim. Dr. Scholz’s extensive involvement with leading health organizations and her continuous contributions to public health policy highlight the respect and trust she commands within the cardiovascular and tobacco control communities. Her work aligns with the global health agenda, earning her recognition as a leading advocate and innovator in preventive cardiology and tobacco harm reduction.

🔬 Research Focus

Dr. Jaqueline Scholz’s research focuses on tobacco dependency treatment, smoking cessation strategies, and their direct impact on cardiovascular health outcomes. Her work bridges clinical practice, digital health innovation, and public health policy to develop effective, scalable interventions for tobacco users. At InCor, she leads studies on novel cessation methodologies, including the integration of digital platforms like the PAF software and automated chatbots to enhance patient support, particularly during public health crises like COVID-19. She has contributed to global tobacco control frameworks through collaborations with the World Health Organization, emphasizing the cardiovascular consequences of smoking and advocating for robust public health responses. Her research also informs state-level policy development, contributing to evidence-based regulations and campaigns targeting smoking reduction. Dr. Scholz’s work aims to reduce the global burden of cardiovascular diseases by addressing one of its leading risk factors—tobacco use—through innovative, patient-centered, and policy-driven approaches.

✅ Conclusion

Dr. Jaqueline Scholz is a globally recognized cardiologist whose innovative clinical work, pioneering research, and leadership in public health policy have made substantial contributions to tobacco cessation and cardiovascular health, aligning with global efforts to reduce smoking-related morbidity and mortality.

Publications

  • Nicotine Dependence in a Banned Market: Biomarker Evidence from E-Cigarette Users in São Paulo, Brazil

    International Journal of Environmental Research and Public Health
    2025-06-19 | Journal article
    DOI: 10.3390/ijerph22060960
    CONTRIBUTORS: Jaqueline Ribeiro Scholz; Elaine Cristine D’Amico; Juliana Takitane; Daniele Mayumi Sinagawa; João Mauricio Castaldelli-Maia; Marcelo Filonzi dos Santos; Rodrigo Alves de Oliveira; Guilherme Vinicius Marques; Eric Nagamine Lima; Diana Fernanda Lasso Rodriguez et al.

  • Smoking cessation decreases arterial blood pressure in hypertensive smokers: A subgroup analysis of the randomized controlled trial GENTSMOKING

    Tobacco Induced Diseases
    2024-05-16 | Journal article
    DOI: 10.18332/tid/186853
    CONTRIBUTORS: Patricia V. Gaya; Guilherme Wesley P. Fonseca; Lucas Tsuyoshi Tanji; Tania O. Abe; Maria Janieire N. N. Alves; Paulo Caleb Junior de Lima Santos; Fernanda M. Consolim Colombo; Jaqueline R. Scholz

  • Posicionamento da Sociedade Brasileira de Cardiologia sobre o Uso de Dispositivos Eletrônicos para Fumar – 2024

    Arquivos Brasileiros de Cardiologia
    2024-02-08 | Journal article
    DOI: 10.36660/abc.20240063
    CONTRIBUTORS: Jaqueline R. Scholz; Deborah Carvalho Malta; Antonio Aurélio de Paiva Fagundes, Júnior; Ricardo Pavanello; Gerson Luiz Bredt, Júnior; Mário de Seixas Rocha

  • Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion

    Frontiers in Pharmacology
    2022 | Journal article
    DOI: 10.3389/fphar.2022.900112

    EID:

    2-s2.0-85135484127

    Part of ISSN: 16639812
    CONTRIBUTORS: Tomaz, P.R.X.; Gonçalves, T.S.; Santos, J.R.; Scholz, J.; Abe, T.O.; Gaya, P.V.; Figueiredo, E.C.; de Faria, H.D.; Martins, I.; Pego, A.M.F. et al

Valeria Azevedo de Almeida | Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Valeria Azevedo de Almeida | Health Sciences | Best Researcher Award

Valéria Azevedo de Almeida is a Brazilian physiotherapist and researcher with expertise in neuroengineering, maternal and child health, and neonatal care. She is currently pursuing a Ph.D. in Physiotherapy at the Federal University of Rio Grande do Norte (UFRN), where she also completed her undergraduate studies. Valéria holds a Master’s in Neuroengineering from the Edmond and Lily Safra International Institute of Neurosciences and has extensive experience in hospital and academic settings. Her research contributions focus on neonatal neural activity and pediatric urological sequelae linked to congenital infections like Zika virus. She has served in both clinical and academic roles across various Brazilian institutions, including UFRN, ISD, HU-UFGD, and HRG. Fluent in Portuguese and proficient in English, she also acts as a journal referee and participates in numerous collaborative health projects. Valéria has earned distinctions for her dedication to education and contributions to neonatal physiotherapy research and care.

Profile

Education 🎓

Valéria Azevedo de Almeida is completing her Ph.D. in Physiotherapy (2021–2025) at UFRN, under Dr. Silvana Alves Pereira. She earned a Master’s in Neuroengineering (2018–2020) at the Edmond and Lily Safra Institute, supervised by Dr. Reginaldo Freitas Jr., with a CAPES scholarship. Previously, she completed a specialization in Maternal and Child Health through a multiprofessional residency at UFRN (2016–2018), also under Dr. Pereira. Her undergraduate degree in Physiotherapy (2011–2015) was completed at UFRN with CNPq scholarship support. Complementary education includes over 20 short courses in areas like public health, intensive care, clinical pilates, neonatal care, and professional development, offered by institutions such as FIOCRUZ, CEDEP, UFMG, and the Albert Einstein Institute. These reflect her commitment to continuous learning and interdisciplinary training in health care and leadership. She also completed a 240-hour English language course and has participated in multiple training programs since 2009, enhancing her clinical and academic capacities.

Experience 👨‍🏫

Valéria has accumulated rich experience in public health, academic research, and clinical physiotherapy. Since 2022, she works at the University Hospital of Grande Dourados (HU-UFGD/Ebserh) as a government-employed physiotherapist. She has concurrently held research and academic roles at UFRN since 2021. Her past positions include clinical roles at Hospital Rio Grande, Hospital Municipal de Campanha, and UPA Esperança, and academic/research posts at Instituto Santos Dumont (ISD), where she contributed to projects on Zika-related pediatric sequelae. From 2016 to 2018, she was a research fellow at the Regional Hospital Dr. Mariano Coelho. Her early experience includes a scholarship-based position at Hospital Universitário Ana Bezerra. She’s also an active participant in ongoing projects at Instituto Fernandes Figueira and ISD. Valéria’s work combines hands-on physiotherapeutic care with clinical research, specializing in neonatal, neurological, and urological rehabilitation, making her a key contributor in multidisciplinary health teams.

Awards & Recognitions 🏅

Valéria received an Honorable Mention in 2018 from the Escola Multicampi de Ciências Médicas do RN for her contribution to the first class of the multiprofessional residency in maternal and child health. In 2015, she won first place in the area of Neonatal and Pediatric Physiotherapy at the III Northeastern Congress of Cardiorespiratory and Intensive Care Physiotherapy (CONEFIR), highlighting her excellence as a student-researcher. These awards recognize her early and continued dedication to improving clinical physiotherapy practice in neonatal and pediatric populations, as well as her commitment to rural health education and service delivery. Her leadership in education and practical training programs, especially in underserved areas, has been widely acknowledged. These honors underscore her impact on both the academic and practical dimensions of physiotherapy and affirm her growing reputation as a committed clinician, researcher, and mentor in Brazil’s evolving healthcare landscape.

Research Interests 🔬

Valéria’s research focuses on neonatal neurophysiology, pediatric rehabilitation, and health impacts of congenital infections such as the Zika virus. At UFRN, her Ph.D. work investigates the relationship between neural activity and visual processing in premature newborns. Through the Instituto Santos Dumont and Instituto Fernandes Figueira, she has contributed to long-term studies on urinary and intestinal dysfunctions in children with congenital Zika syndrome. She integrates neuroengineering principles into pediatric physiotherapy to enhance diagnostic and rehabilitative outcomes. Her interdisciplinary approach includes neurodevelopmental monitoring, urological sequelae analysis, and intervention design for affected children. In addition to field research, she is involved in designing care protocols, training health professionals, and evaluating public health strategies. Her work bridges neuroscience, physiotherapy, and maternal-child care, aiming to improve outcomes for vulnerable pediatric populations. She also serves as a peer reviewer, contributing to the advancement of evidence-based practices in neurorehabilitation and child health.

Publications

Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur Müdüroğlu Kırmızıbekmez is a neuroscientist at İstanbul Nişantaşı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinson’s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TÜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education 🎓

Aynur Müdüroğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimer’s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynur’s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience 👨‍🏫

With over a decade of experience, Aynur Müdüroğlu Kırmızıbekmez has been an Assistant Professor at İstanbul Nişantaşı University since 2014. She has led multiple national and international neuroscience projects, including TÜSEB-approved research on Parkinson’s and Alzheimer’s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests 🔬

Aynur Müdüroğlu Kırmızıbekmez’s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimer’s, Parkinson’s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynur’s projects also include SNP-based qPCR diagnostic tools for Alzheimer’s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions 🏅

Aynur Müdüroğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TÜSEB for her groundbreaking research in stem cell therapy for Parkinson’s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TÜBİTAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications 📚

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Başpınar Küçük H, Zaim M, Şentürk AM, Müdüroğlu Kırmızıbekmez
    A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erözden AA, Tavşanlı N, Müdüroğlu A, Çalışkan M, Kara İ. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, Müdüroğlu Kirmizibekmez Aynur, Altunel Emine Özlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)